Lathosterol is a crucial marker measured in the Boston Heart Cholesterol Balance® test, providing valuable insights into cholesterol production within the body. As a precursor in the biosynthesis of cholesterol, lathosterol levels directly reflect the rate of endogenous cholesterol synthesis. Elevated levels of lathosterol indicate increased cholesterol production, which can be a critical factor in assessing cardiovascular disease risk. By quantifying lathosterol, the Boston Heart Cholesterol Balance® test offers a detailed understanding of an individual's cholesterol metabolism, enabling healthcare providers to tailor treatment strategies more effectively. This marker is instrumental in guiding decisions on therapeutic interventions such as statins, aimed at lowering cholesterol levels and improving overall cardiovascular health.

The LDL Phenotype Pattern describes the size and density of LDL (Low-Density Lipoprotein) particles in your blood — a key factor in assessing heart and metabolic health. LDL isn’t just one kind of cholesterol particle. It comes in different forms: Pattern A: Large, buoyant LDL particles (less harmful) Pattern B: Small, dense LDL particles (more harmful) This test helps identify which LDL type dominates in your blood. Even if your total LDL cholesterol level appears normal, the particle size and type can strongly influence your risk for heart disease, insulin resistance, and metabolic syndrome.

LDL particles vary in size, ranging from small, dense “Pattern B” particles to large, buoyant “Pattern A” particles. Smaller LDL particles are associated with an increased risk for heart disease. Small, dense LDL (“Pattern B”) is associated with insulin resistance or diabetes.